Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.3425
-0.0242 (-6.60%)
At close: Oct 23, 2026, 4:00 PM EDT
0.3680
+0.0255 (7.45%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $5.26 million as of October 23, 2026. It is the 44,650th most valuable company in the world and the 5,961st biggest in the United States. Its market cap has decreased by 72.15% in one year.
Market Cap
5.26M
Enterprise Value
247.64K
1-Year Change
-72.15%
Global Rank
Country Rank
#5,961 United States
Category
ChartMarket Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $399.20M to $5.26M, a decrease of -98.68%. That is a compound annual growth rate of -27.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.26M | -41.52% |
| Dec 31, 2025 | 9.00M | -66.54% |
| Dec 31, 2024 | 26.90M | 71.34% |
| Dec 29, 2023 | 15.70M | 16.30% |
| Dec 30, 2022 | 13.50M | -74.67% |
| Dec 31, 2021 | 53.30M | -38.10% |
| Dec 31, 2020 | 86.10M | 2,677.42% |
| Dec 31, 2019 | 3.10M | -74.17% |
| Dec 31, 2018 | 12.00M | -18.92% |
| Dec 29, 2017 | 14.80M | -3.27% |
| Dec 30, 2016 | 15.30M | -35.71% |
| Dec 31, 2015 | 23.80M | -66.67% |
| Dec 31, 2014 | 71.40M | -70.98% |
| Dec 31, 2013 | 246.00M | -38.38% |
| Jul 25, 2013 | 399.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 5.81M |
| Alaunos Therapeutics | 5.79M |
| Evogene | 5.76M |
| Alzamend Neuro | 5.45M |
| Pulmatrix | 5.41M |
| Niki BioSolutions | 5.38M |
| Longeveron | 5.10M |
| Lexaria Bioscience | 5.09M |